Financial Counselors Inc’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,600
| Closed | -$460K | – | 241 |
|
|
2025
Q1 | $460K | Sell |
3,600
-111
| -3% | -$15.1K | 0.01% | 422 |
|
|
2024
Q4 | $491K | Sell |
3,711
-60
| -2% | -$8.44K | 0.01% | 412 |
|
|
2024
Q3 | $549K | Hold |
3,771
| – | – | 0.01% | 412 |
|
|
2024
Q2 | $518K | Buy |
3,771
+141
| +4% | +$18.8K | 0.01% | 396 |
|
|
2024
Q1 | $498K | Sell |
3,630
-470
| -11% | -$64.2K | 0.01% | 413 |
|
|
2023
Q4 | $557K | Sell |
4,100
-933
| -19% | -$114K | 0.01% | 390 |
|
|
2023
Q3 | $615K | Buy |
5,033
+1,384
| +38% | +$176K | 0.01% | 365 |
|
|
2023
Q2 | $463K | Buy |
3,649
+23
| +0.6% | +$2.99K | 0.01% | 366 |
|
|
2023
Q1 | $468K | Buy |
3,626
+631
| +21% | +$82.6K | 0.01% | 363 |
|
|
2022
Q4 | $393K | Buy |
2,995
+311
| +12% | +$40.2K | 0.01% | 396 |
|
|
2022
Q3 | $314K | Sell |
2,684
-327
| -11% | -$40.6K | 0.01% | 408 |
|
|
2022
Q2 | $354K | Buy |
3,011
+32
| +1% | +$3.8K | 0.01% | 401 |
|
|
2022
Q1 | $388K | Sell |
2,979
-226
| -7% | -$29.4K | 0.01% | 392 |
|
|
2021
Q4 | $489K | Sell |
3,205
-624
| -16% | -$96.6K | 0.01% | 366 |
|
|
2021
Q3 | $619K | Sell |
3,829
-1,251
| -25% | -$211K | 0.01% | 349 |
|
|
2021
Q2 | $831K | Sell |
5,080
-14,798
| -74% | -$2.28M | 0.02% | 326 |
|
|
2021
Q1 | $2.99M | Sell |
19,878
-5,319
| -21% | -$845K | 0.07% | 225 |
|
|
2020
Q4 | $3.82M | Buy |
25,197
+874
| +4% | +$125K | 0.1% | 189 |
|
|
2020
Q3 | $3.29M | Buy |
24,323
+2,390
| +11% | +$324K | 0.1% | 184 |
|
|
2020
Q2 | $3M | Buy |
+21,933
| New | +$2.8M | 0.1% | 194 |
|
|
2020
Q1 | – | Sell |
-1,701
| Closed | -$205K | – | 515 |
|
|
2019
Q4 | $205K | Buy |
+1,701
| New | +$190K | 0.01% | 514 |
|
|
2019
Q1 | – | Sell |
-2,157
| Closed | -$208K | – | 537 |
|
|
2018
Q4 | $208K | Buy |
2,157
+50
| +2% | +$5.31K | 0.01% | 425 |
|
|
2018
Q3 | $257K | Sell |
2,107
-237
| -10% | -$27.9K | 0.01% | 433 |
|
|
2018
Q2 | $257K | Sell |
2,344
-23,197
| -91% | -$2.48M | 0.01% | 426 |
|
|
2018
Q1 | $2.73M | Buy |
25,541
+784
| +3% | +$86.9K | 0.13% | 176 |
|
|
2017
Q4 | $2.64M | Buy |
24,757
+5,911
| +31% | +$632K | 0.12% | 187 |
|
|
2017
Q3 | $2.1M | Sell |
18,846
-3,405
| -15% | -$364K | 0.1% | 207 |
|
|
2017
Q2 | $2.3M | Buy |
22,251
+3,645
| +20% | +$359K | 0.11% | 197 |
|
|
2017
Q1 | $1.82M | Buy |
+18,606
| New | +$1.78M | 0.09% | 217 |
|
Other funds holding IBB
CB
Financial Counselors Inc's IBB Position: Q2 2025 in Review
Financial Counselors Inc sold out of iShares Biotechnology ETF (IBB) in Q2 2025, closing a stake of 3,600 shares — an estimated $460K sold.
Financial Counselors Inc first reported a position in IBB in Q1 2017 and held it in 29 quarters. The position peaked at $3.82M in Q4 2020. 797 funds tracked by Wall St. Rank hold IBB as of Q2 2025.
- Financial Counselors Inc reported no remaining iShares Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
- Financial Counselors Inc sold 3,600 iShares Biotechnology ETF shares in Q2 2025, an estimated $460K.
- Financial Counselors Inc first reported a position in iShares Biotechnology ETF in Q1 2017 and held it in 29 quarters.
- Financial Counselors Inc's iShares Biotechnology ETF position peaked at $3.82M in Q4 2020.
- 797 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2025.
Based on Financial Counselors Inc's 13F filing for Q2 2025, filed 1 Aug 2025.